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It remains unclear how misfolded membrane pro-
teins are selected and destroyed during endoplasmic
reticulum-associated degradation (ERAD). For ex-
ample, chaperones are thought to solubilize aggre-
gation-prone motifs, and some data suggest that
these proteins are degraded at the ER. To better
define how membrane proteins are destroyed, the
ERAD of Ste6p*, a 12 transmembrane protein, was
reconstituted. We found that specific Hsp70/40s
act before ubiquitination and facilitate Ste6p* associ-
ationwith an E3 ubiquitin ligase, suggesting an active
role for chaperones. Furthermore, polyubiquitination
was a prerequisite for retrotranslocation, which re-
quired the Cdc48 complex and ATP. Surprisingly,
the substrate was soluble, and extraction was inde-
pendent of a ubiquitin chain extension enzyme
(Ufd2p). However, Ufd2p increased the degree of
ubiquitination and facilitated degradation. These
data indicate that polytopic membrane proteins can
be extracted from the ER, and define the point of
action of chaperones and the requirement for
Ufd2p during membrane protein quality control.
INTRODUCTION
Newly synthesized soluble secretory and transmembrane pro-
teins fold in the endoplasmic reticulum (ER), but those that fail
to achieve their correct conformations may be retained in the
ER and degraded by the cytoplasmic proteasome via a process
referred to as ER-associated degradation (ERAD) (Kostova and
Wolf, 2003; Meusser et al., 2005; Romisch, 2005; Nishikawa
et al., 2005). Current evidence suggests that different ERAD
pathways are employed depending on the location of the mis-
folded lesion and that molecular chaperones and chaperone-
like lectins help select ERAD substrates (Carvalho et al., 2006;
Denic et al., 2006; Nishikawa et al., 2005; Vashist and Ng,
2004). Soluble ERAD substrates are retrotranslocated, or dislo-
cated from the ER to the cytoplasm after selection, and are easily
accessed by the proteasome. In contrast, the identification and
targeting of membrane proteins—particularly those that pos-
sess multiple transmembrane spans—are likely to involve moreelaborate machineries given substrate complexity and difficul-
ties during substrate solubilization and proteasome recruitment.
The vast majority of ERAD substrates are ubiquitinated by E2
conjugating enzymes and E3 ligases, which, respectively, cata-
lyze the transfer of ubiquitin from a ubiquitin activating enzyme
(E1) and are thought to aid in substrate recognition (Elsasser
and Finley, 2005). In the yeastSaccharomyces cerevisiae, two in-
tegral membrane E3 ligase complexes, the Hrd1p complex and
the Doa10p complex, play important roles during ERAD (Car-
valho et al., 2006; Vashist and Ng, 2004). Both Hrd1p and
Doa10p possess a RING domain on the cytoplasmic face of
the ER and function with the ER-associated E2 enzymes,
Ubc6p and Ubc7p (Gardner et al., 2001; Swanson et al., 2001).
Although Hrd1p and Doa10p may directly recognize an unfolded
domain or a specific amino acid motif (Bays et al., 2001; Gardner
and Hampton, 1999; Ravid et al., 2006), molecular chaperones
contribute to substrate ubiquitination. Chaperones can help pre-
vent the aggregation of misfolded lumenal proteins and soluble
domains in membrane proteins during ERAD (Meachum et al.,
1999; Nishikawa et al., 2005); therefore, the simplest view is
that they augment substrate access to E3 ligases. However, re-
cent reports suggested that an Hsp70-containing or putative lec-
tin-containing complex in the ER helps recruit a misfolded sub-
strate to the Hrd1p complex (Hebert et al., 2005; Denic et al.,
2006; Gauss et al., 2006). Moreover, in vivo studies have demon-
strated that cytoplasmic chaperones form a high-order network,
which may specifically escort substrates to folding or degrada-
tion pathways (Albanese et al., 2006; McClellan et al., 2005;
Meunier et al., 2002; Wang et al., 2006). Overall, the mechanism
by which chaperones facilitate the degradation of a given class
of substrates is not well understood.
After selection, ubiquitinated ERAD substrates are delivered to
the 26S proteasome, which is composed of two 19S ‘‘caps’’
(PA700) that mediate substrate deubiquitination and ATP-
dependent unfolding and a single proteolytic 20S ‘‘core’’ (Voges
et al., 1999). Proteasome delivery requires an ER-associated
AAA ATPase, Cdc48p (in yeast) or p97 (in mammals) (Jentsch
and Rumpf, 2007). During the degradation of membrane pro-
teins, Cdc48p might actively pull a transmembrane domain
and a subsequent lumenal domain from the ER (Carlson et al.,
2006; Ye et al., 2003; Ravid et al., 2006). Alternatively, Cdc48p
might ‘‘segregate’’ a polypeptide that has already been ex-
tracted or retrotranslocated from the ER membrane. Cdc48p
might also act after retrotranslocation of the ERAD substrate
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proteins, including the E4 polyubiquitin chain extension enzyme,
Ufd2p (Richly et al., 2005; Rumpf and Jentsch, 2006).
In principle, the degradation of polytopic membrane sub-
strates could start from either end of the polypeptide, as
proposed for FtsH in bacteria (Akiyama and Ito, 2003), or degra-
dation may commence from an internal site after an endoproteo-
lytic ‘‘clip’’ (Liu et al., 2003; Piwko and Jentsch, 2006). In these
models, it is assumed that degradation and retrotranslocation
are tightly coupled and occur at the ER membrane (Mayer
et al., 1998; Plemper et al., 1998; Xiong et al., 1999). On the other
hand, degradation intermediates of various soluble and mem-
brane substrates have been detected in the cytosol (Carlson
et al., 2006; Jarosch et al., 2002; McCracken and Brodsky,
1996; Meusser and Sommer, 2004; Wiertz et al., 1996). In addi-
tion, treatment of cells with proteasome inhibitors can result in
the cytosolic deposition of aggregated Cystic Fibrosis Trans-
membrane conductance Regulator (CFTR) and other polytopic
membrane substrates. The resulting aggresomes concentrate
at a pericentriolar locus (Johnston et al., 1998; Wigley et al.,
1999), suggesting that ubiquitinated membrane proteins can
be degraded in the cytoplasm after they are completely released
from the ER membrane.
To define the ERAD of misfolded polytopic membrane pro-
teins, we reconstituted each step in this reaction using compo-
nents (either microsomes or cytosol) prepared from the yeast
S. cerevisiae. We demonstrate that ER membrane-associated
Hsp70 and Hsp40s assist the recognition of a substrate by the
E3 ligase, Doa10p, and must act ‘‘in cis,’’ and that Cdc48p binds
to the ubiquitinated substrate and releases it from the ER mem-
brane. Further, we show that Ufd2p elongates the polyubiquitin
chain before the substrate is processed by the proteasome.
Substrate ubiquitination could also be reconstituted with two
other integral membrane proteins (CFTR and Sec61-2p). Thus,
our system is robust and in principle may be employed to eluci-
date the ERAD pathway of any membrane protein that can be
expressed in yeast.
RESULTS
Ste6p* Ubiquitination In Vitro Requires the Same E2s,
E3s, and Chaperones as Those that Facilitate
ERAD In Vivo
Ste6p*, a 12 transmembrane ERAD substrate, is retained in the
ER and is degraded by the proteasome in yeast. In addition, deg-
radation is slowed when specific E2 conjugating enzymes
(Ubc6p and Ubc7p), E3 ligases (Doa10p and Hrd1p), an Hsp70
(Ssa1p), and functionally redundant Hsp40s (Ydj1p and Hlj1p)
are disabled (Huyer et al., 2004; Loayza et al., 1998; Vashist
and Ng, 2004). Because the ERAD pathway for this substrate
is relatively well-defined, and because of its structural similarity
to CFTR, Ste6p* was selected for our first attempts to reconsti-
tute the destruction of a constitutively degraded membrane pro-
tein. ER-derived microsomes were prepared from cells express-
ing HA-tagged Ste6p*, and the membranes were incubated with
yeast cytosol (which supplies the E1 ubiquitin activating enzyme
and other factors potentially needed for ERAD), an ATP regener-
ating system, and 125I-labeled ubiquitin (125I-Ub). We chose
125I-Ub because the subsequent isolation of the ubiquitinated102 Cell 132, 101–112, January 11, 2008 ª2008 Elsevier Inc.substrate would provide quantitative data. After Ste6p* was im-
munoprecipitated with anti-HA antibody and resolved by SDS-
PAGE, ubiquitinated Ste6p* was observed as a ‘‘smear’’ with
a minimum molecular mass of 140 kDa, which corresponds
to the native size of Ste6p* (Figure 1A, upper panel, lanes 2
Figure 1. Ste6p* Is Ubiquitinated In Vitro
(A) Microsomes containing Ste6p* were incubated with 2 mg/ml cytosol, an
ATP regenerating system and 125I-labeled ubiquitin at 23C or on ice for the
indicated times before the reaction was quenched and Ste6p* was immuno-
precipitated with anti-HA antibody. Immunoprecipitates were resolved by
SDS-PAGE and the products were visualized by phosphor imager (top) or
western blot analysis (bottom). Where indicated, reactions were prepared
without cytosol, or with 0.02 u/ml apyrase (‘‘-ATP’’), 0.5 mg/ml methylated ubiq-
uitin (‘‘Me-Ub’’), or 100 mMofMG132; ‘‘-anti-HA’’ denotes that the precipitation
was performed in the absence of antibody, and ‘‘-Ste6p*HA’’ denotes that
microsomes were prepared from cells lacking Ste6p*HA.
(B) In vitro ubiquitination requires E2 and E3 enzymes. Microsomes were pre-
pared from the indicated cells expressing Ste6p*HA, and the in vitro reaction
was performed in the presence of WT cytosol (4 mg/ml) at 23C for the indi-
cated times. In (A) and (B), the arrowhead indicates the 4% stacking gel-6%
running gel boundary, the arrow indicates immunodetected Ste6p*, and the
asterisk indicates IgG; mic, microsomes.
Figure 2. Ste6p* Ubiquitination Requires the Hsp70 and Hsp40
Chaperones
(A) Microsomes were prepared by glass bead disruption from the indicated
cells expressing Ste6p*HA grown at 23C and shifted to 37C for 45 min. Cy-
tosol (‘‘cyt’’) was prepared from the same strains at 26C and shifted to 37C
for 45 min. Reactions were performed with 1 mg/ml cytosol at 23C for 20 min
(left panel) or 30C for 40 min (right panel). Although Ste6p* is expressed in
ydj1-151/hlj1D cells at lower levels than in the isogenic WT strain (lanes 6
and 8), there is a 30%–70% reduction in ubiquitination efficiency in replicated
assays.
(B) Exogenously added Ssa1p and Ydj1p improve ubiquitination efficiency. Mi-
crosomes from WT cells were preincubated with 1.75 mM (lane 3) or 2.5 mM
(lane 4) Ssa1p/Ydj1p and an ATP regenerating system at 23C for 5 min and
shifted to 37C for 15 min before 125I-labeled ubiquitin and WT cytosol
(1 mg/ml) were added and the reaction was incubated at 23C for 40 min.
The reaction was also performed either without chaperones (lanes 1 and 2),
or in the presence of 2.5 mM BSA (lane 5).
(C) Sec61-2p ubiquitination is Ssa1p-independent. Microsomes were pre-
pared by glass bead disruption from sec61-2/SSA1 and sec61-2/ssa1-45 cells
grown at 23C and shifted to 37C for 45 min, and cytosol was prepared from
SSA1 and ssa1-45 cells as in (A). The reaction was performed with 1 mg/ml
cytosol at 30C for 50 min. The double asterisk indicates 125I-labeled contam-
inants in bovine ubiquitin that are immunoprecipitated with anti-Sec61p anti-
serum (see Figure S3).
(D) In vivo ubiquitination of Ste6p* is Ssa1p-dependent. Microsomes were
prepared by glass bead disruption from cells expressing Ste6p*HA andand 3). Substrate ubiquitination depended upon cytosol, physio-
logical temperature, and ATP (Figure 1A, upper panel, lanes
4, 5, and 7). Methylated ubiquitin (Me-Ub), an inhibitor
for polyubiquitin chain formation (Hershko and Heller, 1985),
reduced the extent of ubiquitination (Figure 1A, upper panel,
lane 8). The addition of MG132, a proteasome inhibitor, did not
alter the amount of either the polyubiquitinated protein or the
unmodified protein (see below). Consistent with in vivo data, mi-
crosomes lacking Ubc6p and Ubc7p failed to support Ste6p*
ubiquitination (Figure 1B, lanes 2 and 8). Other in vivo data indi-
cated that depletion of Doa10p does not completely inhibit
Ste6p* turnover, possibly because Hrd1p partially compensates
for Doa10p’s absence (Huyer et al., 2004; see Figure S1 available
online). Indeed, microsomes lacking Doa10p or Hrd1p sup-
ported Ste6p* ubiquitination, whereas the simultaneous deletion
of the genes encoding these enzymes inhibited ubiquitination
(Figure 1B, lanes 3–6 and 9–12).
The Hsp70 chaperone, Ssa1p, and the Hsp40 cochaperones,
Ydj1p andHlj1p, are required for Ste6p* ERAD in vivo, and as ob-
served for other substrates these Hsp70 and Hsp40 homologs
facilitate substrate ubiquitination (Han et al., 2007; reviewed in
Nishikawa et al., 2005). However, their mechanism of action
has not been investigated. We therefore prepared cytosol and
Ste6p*-containing microsomes from wild-type SSA1 and tem-
perature-sensitive ssa1-45mutant cells. Before harvesting, cells
were shifted to a nonpermissive temperature of 37C for 45 min,
which inactivates Ssa1-45p (Becker et al., 1996; Brodsky et al.,
1999). Strikingly, Ste6p* was ubiquitinated in the SSA1 micro-
somes, whereas ssa1-45 mutant microsomes failed to support
ubiquitination (Figure 2A, lanes 2 and 4). A similar result was ob-
tained when microsomes were prepared from a strain bearing
a temperature sensitive allele of YDJ1 (ydj1-151) and a deletion
of HLJ1 (lanes 6 and 8). It is notable that these components
must be supplied in microsomes and that cytosolic supplemen-
tation is ineffective (see Discussion). To generalize these results,
we measured the in vitro ubiquitination of CFTR, whose degra-
dation in yeast similarly depends on Ubc6p/Ubc7p, Doa10p/
Hrd1p and Ssa1p (Gnann et al., 2004; Zhang et al., 2001). As an-
ticipated, CFTR was ubiquitinated in vitro in an ATP, cytosol,
Ubc6p/Ubc7p, and Doa10p/Hrd1p dependent manner, and the
ssa1-45 mutant microsomes failed to support ubiquitination
(Figure S2). Together, the results indicate that the Ssa1p and
Ydj1p/Hlj1p chaperones facilitate substrate ubiquitination.
Because Ssa1p and Ydj1p/Hlj1p play multiple roles during
protein translocation, folding, and degradation (Nishikawa
et al., 2005), we wondered if the impaired ubiquitination of
Ste6p* resulted from a nonspecific secondary effect. However,
we observed that the inclusion of purified Ssa1p/Ydj1p improved
ubiquitination efficiency when added during a preincubation
prior to cytosol addition (Figure 2B). Second, we assayed the
myc-tagged ubiquitin under the control of the CUP1 promoter. DOA10/
HRD1 and doa10D/hrd1D cells were grown at 30C, and SSA1 and ssa1-45
cells were grown at 23C and shifted to 37C for 45 min. Ubiquitin expression
was induced by 100 mM copper sulfate for 3 hr. Where indicated, cells con-
tained a vector control (‘‘-’’). Ste6p*HA was immunoprecipitated and products
were analyzed by western blot analysis with anti-ubiquitin (top panel) or anti-
HA antibodies (bottom panel). A full size blot for the bottom panel is shown
in Figure S4A. Further support for these data is shown in Figure S4B.Cell 132, 101–112, January 11, 2008 ª2008 Elsevier Inc. 103
in vitro ubiquitination of Sec61-2p, an ERAD substrate whose
degradation is independent of Ssa1p (Nishikawa et al., 2001;
Figure S3). Sec61-2p was ubiquitinated in vitro in an ATP- and
cytosol-dependent manner (Figure S3). Moreover, Sec61-2p
ubiquitination was robust in ssa1-45 mutant microsomes
(Figure 2C).
We next asked whether Ste6p* ubiquitination is Ssa1p-depen-
dent in vivo. Consistent with the results obtained from our in vitro
assay, Ste6p* was poorly ubiquitinated in doa10D/hrd1D and
ssa1-45 cells (Figure 2D). Given the fact thatmicrosomes contain
not only unmodified Ste6p* but also ubiquitinated Ste6p*, 125I-
labeled Ub may be attached directly onto Ste6p* and/or onto
pre-existing, ubiquitin chains on Ste6p*. Regardless, our results
demonstrate that cytoplasmic Hsp70/Hsp40 chaperones di-
rectly facilitate Ste6p* ubiquitination in vivo and in vitro and
validate the ability of the in vitro assay to recapitulate cellular
phenomena.
CytoplasmicHsp70FacilitatesSte6p*Binding toDoa10p
Based on these data, we hypothesized that the chaperones facil-
itate the incorporation of Ste6p* into the Doa10p complex and
thus performed a chemical crosslinking experiment. Micro-
somes were prepared from Ste6p*HA and Doa10p13myc-ex-
pressing SSA1 and ssa1-45 cells grown at 23C and shifted to
37C (Figure 3A). Themicrosomeswere then treatedwith amem-
brane-permeable crosslinker (DSP) and Ste6p* was precipitated
with anti-HA antibody. Although Doa10p precipitated with
Ste6p*, approximately half as much of the E3 ligase precipitated
with Ste6p* when Ssa1-45p function was ablated (Figure 3B). In
parallel, we performed the in vitro ubiquitination assay and
observed a corresponding decrease in Ste6p* ubiquitination
(Figure 3C). We also noted that the Doa10p-Ste6p* coimmuno-
precipitation efficiency and Ste6p* ubiquitination efficiency
rose in SSA1 microsomes from cells shifted to 37C. This may
result from the induction of Ssa1p and/or the ubiquitination ma-
chinery. In addition, we employed another crosslinker, DTSSP,
a water-soluble analog of DSP. As shown in one of three repre-
sentative experiments, an 2-fold reduction in Ste6p*-Doa10p
interaction was observed when ssa1-45 microsomes were em-
ployed (Figure 3D, lane 6). Furthermore, we noted a decrease
in Ste6p*-Doa10p association when microsomes from the
ydj1-151/hlj1D strain were used (data not shown). These results
suggest that Hsp70-Hsp40 facilitate Ste6p* ubiquitination by
assisting in E3 ligase recognition.
The Ubiquitination, Degradation, and E3 Interaction
Defects in the ssa1-45 Mutant Are Reversible
Substrate solubility is vital for the ubiquitination and degradation
of ERAD substrates (Nishikawa et al., 2005). Therefore, it was
possible that Ste6p* aggregates in the ssa1 mutant and is ex-
cluded from the Doa10p complex. However, we failed to detect
a significant loss of Ste6p* detergent solubility in ssa1-45mutant
microsomes as compared to WT microsomes when the mixture
was centrifuged at 18,0003 g, a condition at which CFTR aggre-
somes can be pelleted (Johnston et al., 1998) and at 30,0003 g
(Figure S6 and data not shown). We next asked if Ste6p* degra-
dation might be reactivated in ssa1-45mutant cells, which would
otherwise be unlikely if the substrate formed a dead-end aggre-104 Cell 132, 101–112, January 11, 2008 ª2008 Elsevier Inc.gate. Ssa1-45 cells were grown at a nonpermissive temperature
for 40 min and then returned to 23C (Figure 4A). To focus on the
population of Ste6p* which was in a ubiquitination and degrada-
tion-incompetent state, cycloheximide (CHX) was added to the
media before the temperature was lowered. We found that the
Ste6p*-Doa10p interaction (Figure 4B upper and lower panels)
and that Ste6p* ubiquitination and degradation (Figures 4C and
4D, respectively) were restored after the temperature had been
returned to 23C. Moreover, Ssa1p was a component of a puta-
tive multichaperone complex, which may include Ydj1p and
Hsp82p, and Ste6p* (Figure 4E).
Ufd2p Extends the Ubiquitin Chain and Catalyzes
Ste6p* Degradation
Ubiquitin chain assembly usually requires only an E1, an E2, and
an E3. However, polyubiquitination sometimes requires the E4
polyubiquitin chain extension enzyme, which is encoded by
UFD2 (Koegl et al., 1999). Although the degradation of two
ERAD substrates in vivo is slowed when UFD2 is deleted (Richly
et al., 2005), direct evidence for Ufd2p-catalyzed polyubiquitin
chain extension during ERAD is lacking. Of relevance, we noted
that the ubiquitinated Ste6p* species converts from a low to
a high molecular weight form as the concentration of cytosol is
increased (Figure 5A, lanes 1–6). To test whether the observed
ubiquitin extension was Ufd2p-mediated, cytosol and Ste6p*-
expressing microsomes were prepared from WT and ufd2D
cells, and the cytosols were titrated into the in vitro assay.
When Ufd2p was absent in themicrosome fraction (‘‘mic’’), ubiq-
uitin extension was observed. In contrast, when Ufd2p was ab-
sent from cytosol (‘‘cyt’’), Ste6p* remained in the LMW form
(Figure 5A, compare lanes 7–12 and 19–24). To confirm this
result, a GST-Ufd2p fusion protein was purified from bacteria
(Figure 5B) and added into the reaction. As little as 0.5 mg of pu-
rified Ufd2p (1% of total protein) restored ubiquitin elongation
to the HMW form when ufd2D mutant microsomes and cytosol
were examined (Figure 5C, lane 2–4). We then examined the
in vivo ubiquitination state of Ste6p* in WT and ufd2D yeast.
When Ste6p* was immunoprecipitated from cells, the HMW
form was significantly weaker than the LMW form in ufd2D cells
(Figure 5D, compare lanes 3 and 4), but strong ubiquitin overex-
pression in the presence of copper partially suppressed the
ubiquitin extension defect (Figure 5D, lanes 5 and 6). In addition,
the ERADof this substrate was significantly slowed in ufd2D cells
(Figure 5E). These in vitro and in vivo results strongly suggest that
Ufd2p facilitates Ste6p* degradation by increasing the extent of
the polyubiquitin chain.
Polyubiquitinated Ste6p* Solubilization
Is Cdc48p- and ATP-Dependent
Conflicting data have accumulated on whether ubiquitinated
membrane substrates are degraded at the ER membrane or in
the cytoplasm (see Introduction). To test if Ste6p* is released
into the cytosol, we included acentrifugation step after the in vitro
ubiquitination reaction. As the reaction proceeded, 50% of
the ubiquitinated Ste6p* was observed in the supernatant
(Figure 6A, lanes 9–12, upper panel), although most unmodified
Ste6p* remained in the microsomes (bottom panel). Consistent
with the in vitro result, polyubiquitinated Ste6p* was also
Figure 3. Hsp70 Facilitates the Interaction between Ste6p* and Doa10p
(A) Schematic of culturing conditions for microsome preparation.
(B) Chemical crosslinking was performed using microsomes containing Ste6p*HA and Doa10p13myc. Microsomes were prepared as in (A) by glass bead dis-
ruption fromSSA1/DOA10-13myc and ssa1-45/DOA10-13myc cells expressing Ste6p*HA. TheDoa10p13myc fusion protein supports the degradation of amodel
substrate, Deg1-Ura3p (Kreft et al., 2006) and Ste6p* (Figure S5). After crosslinking, Ste6p*HA was immunoprecipitated and resolved by SDS-PAGE under re-
ducing conditions (top two panels). Lysate before antibody addition was also resolved and examined by western blot analysis (bottom two panels) with anti-HA
(Ste6p*) or anti-myc antibody (Doa10p), and a quantification of the coimmunoprecipitated Doa10p13myc is shown in the right panel. (Quantification takes into
account the relative amounts of immunoprecipitated Ste6p*; the amount of material at t = 0 was set to ‘‘1.’’ Note that the crosslinking in lane 6 represents efficient
Ste6p*-Doa10p interaction in the mutant at the permissive temperature.)
(C) The in vitro ubiquitination reaction was performed using microsomes prepared as in (B) and 4 mg/ml cytosol prepared from SSA1 or ssa1-45 yeast as in
Figure 2A. The amount of ubiquitinated Ste6p* is shown in the right panels, and the amount of material at t = 0 in the presence of WT cytosol and microsomes
was set to ‘‘1.’’
(D) Crosslinking with DTSSP was performed using microsomes containing Ste6p*HA and Doa10p13myc prepared from cells shifted to 37C for 60 min as in (A).
Ste6p*HAwas immunoprecipitatedwith anti-HA affinitymatrix. Based on the relative amount of immunoprecipitated Ste6p*, Doa10p-Ste6p* association from the
ssa1-45 strain was 35%–50% as efficient compared to microsomes from WT cells.Cell 132, 101–112, January 11, 2008 ª2008 Elsevier Inc. 105
Figure 4. Ste6p* Remains a Productive Intermediate for Degradation in ssa1 Mutant Yeast
(A) Schematic of culturing conditions for microsome preparation. Ssa1-45 cells expressing Ste6p*HA and Doa10p13myc were grown at 23C, shifted to 37C for
40 min, and CHX was added. Half of the culture was left at 37C (a) and the other half was shifted to 23C (b).
(B) Microsomes were prepared by glass bead disruption from cells grown as in (A). After crosslinking, Ste6p*HA was immunoprecipitated, and Ste6p*HA and
Doa10p13myc were detected as in Figure 3B. The amount of coimmunoprecipitated Doa10p13myc was quantified as in Figure 3B and the means of two inde-
pendent experiments are shown in the bottom panel.
(C) In vitro ubiquitination of Ste6p* was performed using microsomes prepared as in (A). Cytosol was prepared from SSA1 and ssa1-45 yeast as in Figure 2A.
(D) Hsp70 mutant (ssa1-45/DOA10-13myc) cells expressing Ste6p*HA were cultured as in (A) and the degradation of Ste6p* was analyzed by western blot fol-
lowing CHX addition. Sec61p serves as a loading control and the relative amount of Ste6p* remaining over time is indicated below the anti-HA western blot.
(E) Ssa1p is one member of an Ste6p*-associated multiprotein complex. A Triton X-100 solubilized cell lysate was prepared from cells expressing Ste6p*HA and
Doa10p13myc. Ste6p*HA was immunoprecipitated with anti-HA affinity matrix and the indicated proteins were detected by western blot analysis. Cells contain-
ing a vector that lacked the Ste6p* insert were used as a control. Immunoprecipitations were also performed under denaturing conditions (‘‘den’’) to confirm the
identities of distinct proteins and support the efficacy of Hsp70-Hsp40 interaction with the Ste6p* complex. Note, however, that a fraction of Hsp82p was also
precipitated under denaturing conditions.observed in the supernatant when lysates from cim5-1 yeast
were subjected to centrifugation (data not shown). Because
the Cdc48p-Npl4p-Ufd1p complex is required for Ste6p* degra-
dation (Huyer et al., 2004), and contributes to the extraction of
some polypeptides from the ER membrane (Ye et al., 2003;
Jentsch and Rumpf, 2007), we asked if this complex catalyzes
Ste6p* release frommicrosomes. A6.5-fold difference was ob-
served in the liberation of ubiquitinated Ste6p* when reactions
were performed using cytosols from a WT strain and from
a cdc48-3 mutant (Figure 6B, compare lanes 3 and 7, and 4
and 8). A defect in Ste6p* solubilization was also observed in106 Cell 132, 101–112, January 11, 2008 ª2008 Elsevier Inc.the presence of ufd1-1 cytosol (Figure S7). In addition, we found
that a TAP-tagged version of Cdc48p coprecipitated with ubiq-
uitinated substrate (Figure 6C, lane 8). Therefore, the Cdc48p
complex catalyzes Ste6p* release from the membrane.
The HMW Ste6p* species was preferentially released into the
cytosolic fraction (Figure 6A, lanes 9–12). However, Ste6p*
release was unaffected when cytosol andmicrosomes were pre-
pared from ufd2D cells, and in these experiments even the LMW
ubiquitinated species was released from the membrane over
time (Figure S8). These data suggest that the Ufd2p-mediated
extension of the polyubiquitin chain of Ste6p* occurs in the
cytosol, downstream of Cdc48p-mediated release (Figure 6B,
lane 5). Consistent with this hypothesis, Ufd2p is a soluble pro-
tein (Huh et al., 2003; Richly et al., 2005). At this point, however,
we cannot exclude the possibility that Ufd2p may also act on
a membrane-bound population of Ste6p*.
Because the US11-dependent retrotranslocation of MHC
class I heavy chain requires ATP hydrolysis (Ye et al., 2003),
we asked if the Cdc48p-dependent release of Ste6p* requires
ATP. To focus on Cdc48p mediated-release, we took advantage
of the fact that microsomes contain ubiquitinated Ste6p* as well
as unmodified species at steady-state (Figure 2C, top and bot-
tom lanels); therefore, the fate of Ste6p* which had already
been ubiquitinated in vivo could bemonitored. First, microsomes
Figure 5. Ufd2p Elaborates the Ubiquitin
Chain and Facilitates Ste6p* Degradation
(A) In vitro ubiquitination of Ste6p* was assessed
using microsomes prepared from UFD2 or ufd2D
cells expressing Ste6p*HA and cytosol prepared
from UFD2 or ufd2D cells at the indicated concen-
trations. HMW; high molecular weight ubiquiti-
nated species, LMW; lowmolecular weight ubiqui-
tinated species.
(B) Purified GST-Ufd2p and GST were resolved by
SDS-PAGE and stained with Coomassie blue.
(C) In vitro ubiquitination was performed as in (A)
using ufd2D microsomes and cytosol at a final
concentration of 1 mg/ml in the presence of the in-
dicated amounts of the GST-Ufd2p fusion protein
or GST.
(D) In vivo ubiquitination of Ste6p* in UFD2 and
ufd2D cells. Microsomes were prepared from
UFD2 or ufd2D cells expressing Ste6p*HA and
myc-tagged ubiquitin under the control of the
CUP1 promoter. In lanes 3 and 4, copper was
not added, and in lanes 5 and 6, the expression
of ubiquitin was induced by 100 mMcopper sulfate
for 3 hr before the cells were harvested. Ste6p*HA
was immunoprecipitated and analyzed by western
blot analysis with anti-ubiquitin (top panel) or anti-
HA antibodies (bottom panel). The in vivo ubiquiti-
nation of Ste6p* in DOA10/HRD1 and doa10D/
hrd1D cells was analyzed in parallel (lanes 1 and 2).
(E) The degradation of Ste6p*HA inUFD2 or ufd2D
cells was analyzed by western blot analysis of cell
extracts prepared at the indicated time points after
the addition of CHX. Cells were incubated at
30C. The relative amount of Ste6p*wasquantified
and the means of two independent experiments
are shown.
containing Ste6p* were prepared from
cells overexpressing ubiquitin. Then, the
microsomes were incubated with the
WT or cdc48-3 cytosol or buffer and in
the presence or absence of ATP (Fig-
ure 6D). The reaction was subsequently
centrifuged to assess the amount of re-
leased, ubiquitinated Ste6p*. Compared
to reactions using WT microsomes in
the presence of ATP, the level of ubiquiti-
nated Ste6p* released into the cytosol
decreased 2-fold when cdc48-3 cytosol was used (lanes 3 and
6) and was almost absent when WT cytosol lacking ATP was
used (lane 12). These data provide further support that Ste6p*
solubilization requires the Cdc48p complex and ATP.
Polyubiquitinated Ste6p* in the Cytosol Is
Deubiquitinated and/or Degraded by the Proteasome
Finally, we tested if the polyubiquitinated Ste6p* released into
the cytosol was a productive intermediate in the ERAD reaction.
Cytosol containing the released substrate was enriched and free
125I-labeled ubiquitin was removed using a membrane filter. Be-
cause yeast cytosol failed to support the degradation of ubiqui-
tinated Ste6p* (Figure 1A), as reported for another ubiquitinatedCell 132, 101–112, January 11, 2008 ª2008 Elsevier Inc. 107
Figure 6. In Vitro Polyubiquitinated Ste6p* Is Released from the Membrane by the Cdc48p Complex
(A) In vitro ubiquitination of Ste6p* was performed for the indicated times and microsome and cytosol fractions were separated by centrifugation before Ste6p*
was immunoprecipitated. Cytosol was prepared from WT cells and used at 4 mg/ml. T, total reaction; P, pellet; S, supernatant.
(B) The same assay was performed as in (A) except that cytosol was prepared from CDC48 and cdc48-3 cells grown at 26C and shifted to 37C for 5 hr. The
reaction was performed using 4 mg/ml cytosol at 23C for 50 min. In lanes 4 and 8, a 2.5-fold volume of supernatant was subjected to immunoprecipitation.
(C) The same assay was performed as in (A) except that 4 mg/ml cytosol prepared from CDC48 or CDC48-TAP cells grown at 30C was used. In lanes 4 and 8
(depicted as S*), an 8.5-fold volume of supernatant was subjected to a nondenaturing immunoprecipitation with IgG Sepharose. The immunocomplex was then
subjected to a second round of immunoprecipitation under denaturing conditions with anti-HA antibody.
(D) Microsomeswere prepared by glass bead disruption fromWT cells expressing Ste6p*HA andmyc-tagged ubiquitin under the control of theCUP1 promoter at
30C. The expression of ubiquitin was induced by 100 mM copper sulfate for 3 hr. Microsomes were incubated with 4 mg/ml of the indicated cytosol and an ATP
regenerating system for 40min at 23C. After separating the microsomes and cytosol by centrifugation, each fraction was subjected to immunoprecipitation with
anti-HA antibody and analyzed by western blot with anti-ubiquitin (top panel) or anti-HA antibodies (bottom panel). Where indicated, cytosol was omitted
(‘‘buffer’’), or 0.02 u/ml of apyrase was added in place of the ATP regenerating system (‘‘-ATP’’).
(E) The supernatant after the in vitro assay was enriched by filtration, and the fate of ubiquitinated Ste6p* was assessed in RRL in the presence of DMSO (lanes
1–4) or 125 mM MG132 and 90 mM epoxomicin (lanes 5–8) for the indicated times. Ste6p* was immunoprecipitated with anti-HA antibody and analyzed by
phosphor imager.substrate (Deshaies et al., 1995), we used rabbit reticulocyte ly-
sate (RRL) (Carlson et al., 2006; Xiong et al., 1999). The 125I-ubiq-
uitinated Ste6p*-enriched cytosol was mixed with RRL and ATP
and Ste6p* degradation was monitored after precipitation. As
shown in Figure 6E, ubiquitinated Ste6p* disappeared over
time, but degradation was slowed upon the addition of protea-
some inhibitors (the disappearance of Ste6p* in the presence
of the inhibitors may arise from contaminating proteases).
When the results of two experiments were averaged, 20% and
40% of the substrate remained after the 40 min incubation in
the absence versus presence of the proteasome inhibitors, re-
spectively. Although the disappearance of the poylubiquitinated108 Cell 132, 101–112, January 11, 2008 ª2008 Elsevier Inc.material may also arise from deubiquitinating enzymes, these
data suggest that the soluble form of Ste6p* is a productive sub-
strate for the proteasome degradation pathway.
DISCUSSION
Polytopic membrane proteins constitute an important class of
macromolecules, representing 20%–30% of the proteome
(Wallin and von Heijne, 1998). Because of their complexity they
are prone to misfold, and indeed many proteins in this class traf-
fic inefficiently beyond the ER (Brodsky, 2007). To better under-
stand the pathway by which these proteins are destroyed, each
Figure 7. A Proposed Pathway for the ERAD
of a Polytopic Membrane Protein
Doa10p, in conjugation with the E2 enzymes
(Ubc6p and Ubc7p), catalyzes Ste6p* ubiquitina-
tion. This step is enhanced by specific ER-associ-
ated Hsp70 andHsp40molecular chaperones that
facilitate Ste6p*-Doa10p association. Ubiquiti-
nated Ste6p* is then recognized by the Cdc48p
complex and can be released into the cytoplasm,
where Ufd2p elaborates the ubiquitin chain. Fi-
nally, polyubiquitinated Ste6p* is deubiquitinated
and/or degraded. At present, it is not clear if cyto-
plasmic Ste6p* is fragmented by the proteasome.
Note that Ubc7p is recruited to the ER membrane
by Cue1p, and the location of the ubiquitinated
residue(s) in Ste6p* are unknown. The proteasome
image was adopted from Voges et al., 1999.step during the ERAD of Ste6p* was reconstituted. Based on
in vivo studies and our findings, a model for the ERAD of
Ste6p* is shown in Figure 7. While it was previously known that
the cytoplasmic Hsp70, Ssa1p, is required for ERAD, we demon-
strate that the chaperone facilitates substrate-E3 ligase interac-
tion. After ubiquitination, Ste6p* is captured by Cdc48p and
released into the cytosol. Next, Ufd2p enhances the extent of
ubiquitination. Finally, the soluble species is a substrate for pro-
teasome-mediated processing. Our results suggest that poly-
topic membrane proteins are ubiquitinated at the ER membrane
but may be released into the cytosol for degradation.
One view of chaperone function is that they bind misfolded
substrates and prevent aggregate formation, thereby promoting
recognition by the ubiquitination machinery. However, recent
studies suggest that cytoplasmic chaperones form a high-order
network and escort substrates to folding or degradative path-
ways (Albanese et al., 2006; McClellan et al., 2005; Wang
et al., 2006). Indeed, we found that Ste6p* remains detergent ex-
tractable after Ssa1p inactivation, and Ste6p*’s interaction with
Doa10p—and its ubiquitination and degradation compe-
tence—are resurrected upon Ssa1p reactivation. In the absence
of functional Ssa1p, Ste6p* solubilitymay bemaintained by other
chaperones, such as Hsp90 (Hsp82p in yeast, Figure S9). There-
fore, a multichaperone assembly may prevent the aggregation of
ERAD substrates, and Hsp70 is most likely a component of this
complex (Figure 4E, but note that distinct members of the com-
plex may bind in a mutually exclusive manner). We also suggest
that Hsp70 promotes Ste6p* recognition by Doa10p. At this time,
it is not clear if Doa10p similarly recognizes a nonnative polypep-
tide motif in ERAD substrates, as proposed for Hrd1p (Bays
et al., 2001), or instead detects a degradation signal (Gardner
and Hampton, 1999; Ravid et al., 2006).
Our inability to complement the Ste6p* ubiquitination defect in
Hsp70 mutant microsomes upon the addition of WT cytosol was
initially surprising (Figure 2A), especially since the ubiquitination
and degradation of Ste6p* could be restored by Hsp70 reactiva-
tion in vivo. Moreover, repeated attempts to rescue the ssa1-45
mutant phenotype upon the addition of purified proteins were
unsuccessful. We propose three models to explain these results.
First, Ste6p* that resides in the Hsp70 mutant microsomes may
be associated with an inert chaperone complex, and thus exter-
nally supplied Hsp70 would be sterically restricted for substrateaccess. Second, Hsp70 may facilitate Ste6p*-Doa10p interac-
tion and ubiquitination by activating membrane-integrated fac-
tors. Therefore, WT cytosol would be unable to rescue the mu-
tant phenotype. Third, Ste6p* in ssa1-45 mutant microsomes
may lack a critical component that would not be supplied from
cytosol or purified chaperones. Nevertheless, we cannot com-
pletely exclude the possibility that Hsp70 modulates Doa10p
by subtly altering its conformation. We note, however, that the
defect in Doa10p-Ste6p* association in ssa1-45 microsomes
was observed using two different crosslinkers, and that
Doa10p solubility is unchanged when microsomes were pre-
pared from either WT or ssa1-45mutant yeast (data not shown).
It is not completely clear how the ER quality control machinery
surveys integrating membrane proteins to identify those that are
inappropriately assembled. Because Ste6p* ERAD was recov-
ereduponSsa1p reactivation andafter translation arrest,we sug-
gest that Doa10p recognizes Ste6p* post-translationally. This
view is consistent with the fact that Ste6p* lacks the C-terminal
42 amino acids found in the full length, WT protein; thus, the con-
formations of translation and translocation intermediates of
Ste6p* and WT Ste6p are identical, and the nature of the Ste6p*
misfolding defect should only be evident post-translationally.
Several lines of evidence indicate that Doa10p is the ligase for
membrane substrates with misfolded cytoplasmic domains,
such as Ste6p* (Carvalho et al., 2006; Vashist and Ng, 2004).
However, degradation and ubiquitination is incompletely in-
hibited when Doa10p is absent, which suggests that Hrd1p con-
tributes to the ubiquitination of this class of substrates (Huyer
et al., 2004; this study). One means to explain this observation
is that cytoplasmic domain misfolding might influence the as-
sembly of the intermembrane domain, which is recognized by
the Hrd1p complex. Alternatively, the Hrd1p complex may rec-
ognize a cytoplasmic misfolded region. Substrates for Hrd1p
are not restricted to lumenal and membrane proteins (Arteaga
et al., 2006). This notion is also supported by the fact that the
degradation of a general amino acid permease requires both
Hrd1p and Doa10p (Kota et al., 2007). Overall, depending on
the topology and the location of the misfolded lesion, complex
polytopic membrane proteins could be sorted to redundant
pathways, which converge at the proteasome.
A long-standing question is whether polytopic ERAD sub-
strates are degraded by the proteasome in situ at the membraneCell 132, 101–112, January 11, 2008 ª2008 Elsevier Inc. 109
or whether they are extracted prior to proteolysis. Because sol-
ubilized, polyubiquitinated Ste6p* was precipitated with anti-HA
antibody, which recognizes a lumenally disposed epitope in
Ste6p*HA, our results indicate that the transmembrane domain
of Ste6p* became solvent-exposed. More generally, our data
provide the first in vitro evidence that aggresomes may form
from the retrotranslocation of a polytopic protein in the ERmem-
brane.
It is unclear whether polytopicmembrane proteins are intact or
clipped prior to or during extraction. We note that the cytoplas-
mic polyubiquitinated species begin at and are higher than the
molecular weight of the native species, suggesting strongly
that unclipped proteins are released into the cytosol. If so, how
is the substrate pulled from the ER? And, how is the solubility
of the membrane domain maintained? The degradation of
Ste6p* does not require proposed retrotranslocation channels
(Huyer et al., 2004; Kreft et al., 2006). Thus, Ste6p* could either
be retrotranslocated through an ill-defined channel or directly
from the membrane. It should be noted that fusion of green fluo-
rescent protein (GFP) to Ste6p* juxtaposed to the HA epitope tag
in the ER lumen does not impair degradation (Huyer et al., 2004),
suggesting that the GFP moiety can be retrotranslocated or
extracted. Alternatively, the reconfiguration of membrane lipids
could support extraction/release, and attached lipids may main-
tain the solubility of transmembrane domains (Ploegh, 2007).
Candidates for proteinaceous factors that could maintain the
solubility of transmembrane domains include cytoplasmic chap-
erones, Cdc48p, proteasome-associated factors such as
Rad23p/Dsk2p (Richly et al., 2005), and the 19S particle. The
in vitro system reported in this study provides a means to
address these questions.
EXPERIMENTAL PROCEDURES
Strains and Plasmids
Yeast strains and plasmids are shown in the Supplemental Data.
In Vitro Ubiquitination Assay
Unless otherwise indicated, ER-derived microsomes were prepared by ho-
mogenization and cytosol was prepared by liquid nitrogen lysis (McCracken
and Brodsky, 1996). Chaperone mutant microsomes were prepared by glass
bead disruption as described in the Supplemental Data. A typical ubiquitina-
tion reaction (20 ml), including 20 mg of microsomes, an ATP regenerating sys-
tem and the indicated concentration of yeast cytosol in buffer 88 (20 mM
HEPES, [pH 6.8], 150 mM KOAc, 250 mM sorbitol, 5 mM MgOAc), was pre-
warmed at 23C (Ste6p*) or at 30C (Sec61-2p) for 10 min. After 2 ml of 125I-la-
beled ubiquitin (1.03106 cpm/ml) was added, the reaction was incubated for
up to 60min. The reaction was quenchedwith 1%SDSplus protease inhibitors
and 10mMN-ethylmaleimide. Ste6p* and Sec61-2pwere immunoprecipitated
with anti-HA antibody or anti-Sec61p antiserum, and were resolved by SDS-
PAGE. Half of each sample was used for phosphor imager analysis and the
other half was used for western blot analysis. Detailed buffer composition
and protocols for the degradation assay are provided in the Supplemental
Data.
Detection of the In Vivo Ubiquitinated Substrate
The extent of the polyubiquitinated substrate in yeast was detected using af-
finity purified anti-ubiquitin antibody (a kind gift fromC. Pickart) or anti-myc an-
tibody (a kind gift from O. Weisz and G. Apodaca) as described (Ahner et al.,
2007).110 Cell 132, 101–112, January 11, 2008 ª2008 Elsevier Inc.Crosslinking Assay
ER-derived microsomes were prepared using buffer 88 at pH 7.5 instead of pH
6.8 from a total of 20–30 OD600 equivalents of log phase cells (OD600 = 1.0),
and 250 mg of microsomes were incubated with the indicated crosslinkers for
60 min on ice. The reaction was quenched with 230 mM Tris pH 7.5, the mem-
branes were solubilized with 1% SDS, insoluble material was removed, and
Ste6p* was immunoprecipitated with anti-HA antibody. The immunoprecipi-
tated proteins were analyzed by SDS-PAGE under reducing conditions and
by western blot analysis with anti-HA or anti-myc antibody. Detailed protocols
on this assay and the native immunoprecipitation are provided in the Supple-
mental Data.
Cycloheximide Chase Degradation Assay
CHX degradation analyses were performed as described previously (Zhang
et al., 2001) with minor modifications (see Supplemental Data).
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, nine fig-
ures, one table, and Supplemental References and can be found with this ar-
ticle online at http://www.cell.com/cgi/content/full/132/1/101/DC1/.
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